Akihiko Uchiyama
24PUBLICATIONS
49CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (24)
Sort by Publication Date:
|Feb 16, 2026
Seventy-Two-Week Real-World Outcomes of Tralokinumab Treatment for Moderate-To-Severe Atopic Dermatitis: Analyses Stratified by Baseline Rash and Itch Severity.Manami Yoneyama, Teppei Hagino, Akihiko Uchiyama
|Feb 11, 2026
Effectiveness of Anti-IL-13 Antibodies on Head and Neck Lesions in Atopic Dermatitis: 48-Week Outcomes by Lebrikizumab and Tralokinumab.Mizuki Shiba, Teppei Hagino, Akihiko Uchiyama
|Jan 05, 2026
Long-Term, Site-Specific Effectiveness of Tralokinumab in Atopic Dermatitis: A 72-Week Real-World Study.Mizuki Shiba, Teppei Hagino, Akihiko Uchiyama
|Jul 25, 2025
Transition of Blood Biomarkers During 24-Week Treatment With Lebrikizumab or Tralokinumab in Atopic Dermatitis: A Real-World Analysis Stratified by Prior Systemic Therapy.Teppei Hagino, Akihiko Uchiyama, Keiji Kosaka
|Jul 23, 2025
Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan.Wataru Sasaki, Ryo Saito, Kenta Suzuki
|Mar 04, 2024
Real-world effectiveness and safety of abrocitinib in 12 Japanese patients with atopic dermatitis and transcriptome analysis with peripheral blood.Akihiko Uchiyama, Keiji Kosaka, Mai Ishikawa
Pageof 4
Frequent Collaborators
23 joint publications
Sei-Ichiro Motegi
11 joint publications
Yukie Endo
7 joint publications
Masahito Yasuda
6 joint publications
Akiko Sekiguchi
4 joint publications
Eita Fujimoto
4 joint publications
Hidehisa Saeki
4 joint publications
Naoko Kanda
4 joint publications
Teppei Hagino
3 joint publications
Keiji Kosaka
2 joint publications
Ken Okamura
